Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanamide SCHEMBL15435940 | 0.85 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5281905 | 0.84 | APOBEC3A (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5944513 | 0.82 | APOBEC3A (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL2059645 | 0.69 | TSHR (0.36) | — | |
| SCHEMBL15293601 | 0.66 | CYP1A2 (0.43) | CHRM2CHRM1CHRM3APOBEC3AAPOBEC3G | |
| SCHEMBL5944446 | 0.65 | ACHE (0.40) | APOBEC3AAPOBEC3G | |
| SCHEMBL16612447 | 0.64 | KMT2A (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL16612732 | 0.64 | KMT2A (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL7074944 | 0.64 | CYP3A4 (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5944497 | 0.63 | POLB (0.42) | APOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2690180-A1 | Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids | Samsung Electronics Co., Ltd (KR) | 2014-01-29 | — | — | EP | disclosed |